HIGHMARK COMMERCIAL MEDICAL POLICY - PENNSYLVANIA

 
 

Medical Policy:
S-203-014
Topic:
Transcatheter Pulmonary Valve Implantation
Section:
Surgery
Effective Date:
September 2, 2024
Issued Date:
September 2, 2024
Last Revision Date:
July 2024
Annual Review:
July 2024
 
 

Transcatheter pulmonary valve implantation (TVPI) using United States (U.S.) Food and Drug Administration (FDA) approved devices is a minimally invasive alternative to surgical pulmonary valve replacement in children and adult individuals with significant right ventricular outflow tract (RVOT) conduit regurgitation or stenosis.

Policy Position

TVPI using an U.S. FDA approved device or system may be considered medically necessary for adult or pediatric individuals with congenital heart disease and current RVOT, regurgitation, or stenosis meeting ALL the following criteria:

  • Individual has existence of a full (circumferential) RVOT conduit that was equal to or greater than 16 mm in diameter when originally implanted and ONE or more of the following:
    • Right ventricle-to-pulmonary artery conduit with or without bioprosthetic valve with at least moderate pulmonic regurgitation
    • Native or patched RVOT with at least moderate pulmonic regurgitation
    • Right ventricle-to-pulmonary artery conduit with or without bioprosthetic valve with pulmonic stenosis (mean RVOT gradient at least 35 mm Hg)
    • Native or patched RVOT with pulmonic stenosis (mean RVOT gradient at least 35 mm Hg)
    • Progressive right ventricular dilation (greater than 150ml/M2) with or without reduced RV ejection fraction and abnormal exercise stress testing
    • Objective exercise intolerance and abnormal RV stress echocardiogram with or without the above noted findings
  • Performing provider and facility meet the recommendations for performing TVP implantation outlined in SCAI/AATS/ACC/STS Operator and Institutional Requirements for Transcatheter Valve Repair and Replacement, Part 111: Pulmonic Valve. 

TVPI not meeting the criteria as indicated in this policy is considered not medically necessary.

33477

 

 

 

 

 

 




Professional Statements and Societal Positions Guidelines

Society for Cardiovascular Angiography and Interventions et al - 2015

The Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American College of Cardiology (ACC), and the Society of Thoracic Surgeons (2015) published a consensus-based report on operator and institutional requirements for transcatheter pulmonary valve implantation (TPVI). Recommendations to qualify for a TPVI program included 150 catheterizations per year, association with a surgical program, submission of all cases to a national registry, and, for patients, 80 percent freedom from reintervention at one (1) year.


Covered Diagnosis Codes for Procedure Code 33477

I37.0

I37.1

I37.2

I37.8

I37.9

I97.0

I97.110

I97.130

I97.190

Q20.5

Q21.3

Q22.0

Q22.1

Q22.2

Q22.3

T82.01XA

T82.01XD

T82.01XS

T82.02XA

T82.02XD

T82.02XS

T82.03XA

T82.03XD

T82.03XS

T82.09XA

T82.09XD

T82.09XS

T82.221A

T82.221D

T82.221S

T82.222A

T82.222D

T82.222S

T82.223A

T82.223D

T82.223S

T82.228A

T82.228D

T82.228S

T82.857A

T82.857D

T82.857S

T82.897A

T82.897D

T82.897S

T82.9XXA

T82.9XXD

T82.9XXS

Z87.74

Z95.2

Z95.3

Z95.4

 

 

 

 



Place of Service: Inpatient



The policy position applies to all commercial lines of business



Links






This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical or other circumstances may warrant individual consideration, based on review of applicable medical records, as well as other regulatory, contractual and/or legal requirements.

Medical policies do not constitute medical advice, nor are they intended to govern the practice of medicine. They are intended to reflect Highmark's reimbursement and coverage guidelines. Coverage for services may vary for individual members, based on the terms of the benefit contract.

Highmark retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Highmark. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.

Discrimination is Against the Law
The Claims Administrator/Insurer complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The Claims Administrator/Insurer does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. The Claims Administrator/ Insurer:

  • Provides free aids and services to people with disabilities to communicate effectively with us, such as:
    • Qualified sign language interpreters
    • Written information in other formats (large print, audio, accessible electronic formats, other formats)
  • Provides free language services to people whose primary language is not English, such as:
    • Qualified interpreters
    • Information written in other languages

If you need these services, contact the Civil Rights Coordinator.

If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P.O. Box 22492, Pittsburgh, PA 15222, Phone: 1-866-286-8295, TTY: 711, Fax: 412-544-2475, email: CivilRightsCoordinator@highmarkhealth.org. You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, the Civil Rights Coordinator is available to help you.

You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at:

U.S. Department of Health and Human Services
200 Independence Avenue, SW
Room 509F, HHH Building
Washington, D.C. 20201
1-800-368-1019, 800-537-7697 (TDD)

Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html.

This information is issued by Highmark Blue Shield on behalf of its affiliated Blue companies, which are independent licensees of the Blue Cross Blue Shield Association.  Highmark Inc. d/b/a Highmark Blue Shield and certain of its affiliated Blue companies serve Blue Shield members in the 21 counties of central Pennsylvania. As a partner in joint operating agreements, Highmark Blue Shield also provides services in conjunction with a separate health plan in southeastern Pennsylvania.  Highmark Inc. or certain of its affiliated Blue companies also serve Blue Cross Blue Shield members in 29 counties in western Pennsylvania, 13 counties in northeastern Pennsylvania, the state of West Virginia plus Washington County, Ohio, the state of Delaware[ and [8] counties in western New York and Blue Shield members in [13] counties in northeastern New York].  All references to Highmark in this document are references to Highmark Inc. d/b/a Highmark Blue Shield and/or to one or more of its affiliated Blue companies.